Century Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-26,423
Closed -$1.48M – 202
2016
Q2
$1.48M Hold
26,423
– – 0.16% 178
2016
Q1
$889K Sell
26,423
-96,933
-79% -$3.29M 0.1% 200
2015
Q4
$5.57M Hold
123,356
– – 0.32% 101
2015
Q3
$4.87M Buy
123,356
+49,553
+67% +$2.82M 0.28% 121
2015
Q2
$4.58M Buy
73,803
+39,352
+114% +$2.34M 0.26% 115
2015
Q1
$2.15M Buy
+34,451
New +$2.1M 0.12% 141

Other funds holding ANIP

Century Capital Management's ANIP Position: Q3 2016 in Review

Century Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2016, closing a stake of 26,423 shares — an estimated $1.48M sold.

Century Capital Management first reported a position in ANIP in Q1 2015 and held it in 6 quarters. The position peaked at $5.57M in Q4 2015. 171 funds tracked by Wall St. Rank hold ANIP as of Q3 2016.

  • Century Capital Management reported no remaining ANI Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Century Capital Management sold 26,423 ANI Pharmaceuticals shares in Q3 2016, an estimated $1.48M.
  • Century Capital Management first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 6 quarters.
  • Century Capital Management's ANI Pharmaceuticals position peaked at $5.57M in Q4 2015.
  • 171 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2016.

Based on Century Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.